VERIGRAFT AB
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine. The company’s unique technology platform turns donated allogeneic (“foreign”) tissue into an autologous-like (“personalized”) tissue and thus avoids transplant rejection and the need for life-long immunosuppression. Donated, allogenic tissue is patient-individualized by a combination of DC (Decellularization) and RC (Reconditioning/Recellularization) processes.... VERIGRAFT’s technology does not require immunosuppression. With this unique, patented and improved alternative to existing treatments, VERIGRAFT strives to deliver a life changing impact to patients and provide major benefits for hospitals, healthcare providers and society – globally. VERIGRAFT’s personalized tissue-engineered vein (P-TEV) has gone through preclinical development at the company. Safety data from large animals has been generated. Clinical proof-of-concept in humans exists. The product is planned to enter clinical development within 6 months.
VERIGRAFT AB
Industry:
Biotechnology Life Science Medical Medical Device
Founded:
2004-01-01
Address:
Gothenburg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.verigraft.com
Total Employee:
11+
Status:
Active
Total Funding:
2.18 M EUR
Technology used in webpage:
Japanese Yen Miss Group
Similar Organizations
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Virustatic
Virustatic is a biotechnology company that develops protein-based antimicrobial, antibacterial, and antifungal textile coating.
Current Employees Featured
Petter Björquist Chief Executive Officer @ Verigraft AB
Chief Executive Officer
Jan Holgersson Co-Founder & Chairman @ Verigraft AB
Co-Founder & Chairman
2017-10-01
Raimund Strehl CTO @ Verigraft AB
CTO
2017-08-01
Edvard Nordfors CFO @ Verigraft AB
CFO
2016-05-01
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Verigraft AB
Official Site Inspections
http://www.verigraft.com
- Host name: cpsrv24.misshosting.com
- IP address: 185.76.64.174
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Verigraft AB"
VERIGRAFT
VERIGRAFT’s focus is to remove rejection from tissue transplantation. Many patients need new tissues or organs. However, transplanted donor tissues are rejected by the patient’s immune …See details»
Company | VERIGRAFT - Personalized Grafts
VERIGRAFT has grown to become a forerunner in industrialized tissue engineering and advanced regenerative medicine. The company has a strategically focused R&D pipeline of personalized …See details»
Innovation | VERIGRAFT - Personalized Grafts
VERIGRAFT focuses on four therapeutic areas; Veins, arteries, peripheral nerves and heart valves. The first clinical application is to treat Chronic Venous Insufficiency, CVI. VERIGRAFT’s lead product, the personalized tissue …See details»
Verigraft AB - Crunchbase Company Profile & Funding
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine. The company’s unique …See details»
VERIGRAFT AB - VentureRadar
Website: http://www.verigraft.com/ Develops personalized tissue-engineered transplants for regenerative medicine, aiming to eliminate transplant rejection and life-long …See details»
VERIGRAFT - LinkedIn
VERIGRAFT generates personalized tissue-engineered transplants for use in regenerative medicine. The company’s unique technology platform turns donated allogeneic (“foreign”) tissue into an...See details»
VERIGRAFT
VERIGRAFT. We are pioneers in the field of regenerative medicine, developing personalized human tissues for transplantation. The current focus area is the development of fully …See details»
VERIGRAFT - Products, Competitors, Financials, Employees, …
VERIGRAFT is a company focused on regenerative medicine, specifically in the domain of tissue engineering and transplantation. Use the CB Insights Platform to explore VERIGRAFT's full …See details»
Investors | VERIGRAFT - Personalized Grafts
VERIGRAFT has the potential to become a major actor on the market for arterial grafts. A market that according to the Vascular Grafts Global Market Report 2023, amounts to US$ 2,96B in 2022, and is expected to grow to US$ 4,1B in 2026 …See details»
VERIGRAFT Company Profile 2024: Valuation, Investors …
VERIGRAFT was founded in 2004. Where is VERIGRAFT headquartered? VERIGRAFT is headquartered in Gothenburg, Sweden. What is the size of VERIGRAFT? VERIGRAFT has 13 total employees. What industry is …See details»
VERIGRAFT - Company Profile & Staff Directory - ContactOut
VERIGRAFT generates personalized tissue-engineered transplants for use in regenerative medicine. The company’s unique technology platform turns donated allogeneic (“foreign”) …See details»
Verigraft reaches 50% recruitment in personalised vein transplant …
Dec 11, 2023 · Verigraft has enrolled half of the planned 15 patients for its first-in-man trial investigating the safety and efficacy of its personalised tissue-engineered veins (P-TEV), …See details»
VERIGRAFT - SwedenBIO
VERIGRAFT makes transplantation possible without the severe risks of immunosuppression, and uses regenerative medicine technology to address so far incurable diseases. The company is …See details»
Verigraft AB - Contacts, Employees, Board Members ... - Crunchbase
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine.See details»
Therapeutic areas | VERIGRAFT - Personalized Grafts
VERIGRAFT’s unique technology provides surgeons with fully-biological, personalized tissue grafts for implantation to patients. The first clinical application is to treat Chronic Venous …See details»
Verigraft AB - Funding, Financials, Valuation & Investors
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine.See details»
Contact | VERIGRAFT - Personalized Grafts
For inquiries relating to partnerships, cooperation, media or investor relations, please contact us by any of the means below. Address. VERIGRAFT AB. Arvid Wallgrens Backe 20. SE-41346 …See details»
Verigraft AB - Crunchbase
Verigraft AB is a biotech company that generates personalized tissue-engineered transplants for use in regenerative medicine.See details»
VERIGRAFT To Use AI To Increase Quality Of Vascular Grafts
Dec 14, 2023 · VERIGRAFT has developed a pioneering technique that uses autologous components from the recipient’s blood to create personalized tissue-engineered veins (P-TEV) …See details»
VERIGRAFT AB to Present at 2023 Cell & Gene Meeting on the Mesa
Sep 26, 2023 · Gothenburg, Sweden September, 2023 – VERIGRAFT announced today that Dr. Petter Björquist, CEO of VERIGRAFT will present at the annual Cell & Gene Meeting on the …See details»